Lipoprotein (a)[Lp (a)] has attracted the interest of researchers and physicians due to its
intriguing properties, including an intragenic multiallelic copy number variation in the LPA …

▪ Abstract Atherosclerosis, the primary cause of coronary artery disease (CAD) and stroke, is
a disorder with multiple genetic and environmental contributions. Genetic-epidemiologic …

Abstract A size polymorphism (K IV VNTR) and largely unknown sequence variation in the
apolipoprotein (a)[apo (a)] gene on chromosome 6q26–q27 together determine most of the …

A variable number of 5.6-kilobase kringle IV repeats in the human apolipoprotein (a)(apo
(a)) gene results in a size polymorphism of the protein and correlates inversely with the …

Plasma lipoprotein (a)(Lp [a]) level is an independent risk factor of cardiovascular disease
that is under strong genetic control. We conducted a genome-wide association study of …

The distributions of plasma lipoprotein (a), or Lp (a), levels differ significantly among ethnic
groups. Individuals of African descent have a two-to threefold higher mean plasma level of …

The aim of this study was to investigate and disentangle the genetic and nongenetic causes
of stability and change in lipids and (apo) lipoproteins that occur during the lifespan. Total …

High plasma concentrations of lipoprotein (a)[Lp (a)], a covalent low-density lipoprotein-
apolipoprotein (a)[apo (a)] complex, are associated with coronary heart disease and stroke …

Abstract Lipoprotein (a)[Lp (a)] is a quantitative genetic trait in human plasma associated
with atherothrombotic disease. The major determinant of Lp (a) concentration is the …

Most studies aiming to detect associations of genetic variation with common complex
diseases, eg coronary heart disease (CHD) have been performed in populations with a …